Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 573Session 2026

What changed between versions

16 paragraphs changed+82 words added−117 removed

Highlighted text was added in the newer version. Struck-through text was removed.

2026 SESSION

HOUSE SUBSTITUTE

INTRODUCED

26107255D26103274D

HOUSE BILL NO. 573

AMENDMENT IN THE NATURE OF A SUBSTITUTE

Offered January 14, 2026

Prefiled January 13, 2026

A BILL to direct the Board of Medicine to develop a patient decision checklist for patients considering breast implants.

—————

Patrons—Glass, Nivar and Thornton

—————

(ProposedReferred by the Houseto Committee on Health and Human Services

on ________________)

(Patron Prior to Substitute—Delegate Glass)

A BILL to direct the Board of Medicine to convene a work group to create educational materials for patients considering breast implants.

—————

Be it enacted by the General Assembly of Virginia:

1. §1. That the Board of Medicine (the Board) shall convenedevelop a workpatient group comprised of plastic surgeons, primary care providers, oncologists, nurse practitioners , physician assistants, and hospitals to create educational materials in electronic and physical form promoting best practiceschecklist for patients considering breast implants. Such materialschecklist shall comply with U.S. Food and Drug Administration requirements for checklists distributed by breast implant manufacturers. Such checklist shall include information on (i) the risks of potential complications from breast implants, (ii) potential development of breast implant-associated anaplastic large cell ly m pho m alymphoma, (iii) the increased chancechange of developdevelopment ingof certaince rtain autoimmune and connective tissue diseases, (iv) the availability of aesthetic flat closure as an alternative, and (v) other systemic symptoms associated with breast implantsim p lants. TheSuch Boardchecklist shall completeinclude theinformation educationalabout materialsaest andhetic distributeflat suchclosure materialsas an alternative to itsbreast licensees by January 1, 2027implants.

Back to the full text